Wells David R. 4
4 · ENDRA Life Sciences Inc. · Filed Jun 24, 2020
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Exercise of In-Money
Common Stock
2020-06-23$0.87/sh+5,000$4,350→ 115,003 total - Exercise of In-Money
Warrants
2020-06-23−5,000→ 5,051 totalExercise: $0.87From: 2019-12-11Exp: 2024-12-11→ Common Stock (5,000 underlying)
Holdings
- 24,786(indirect: By StoryCorp Consulting)
Common Stock
Footnotes (1)
- [F1]Includes unvested restricted stock units.